Markets regulator Sebi on Wednesday allowed co-existence of the current title transfer collateral mechanism and the new pledge and re-pledge process till August 31.

The decision has been taken in view of the prevailing situation due to the COVID-19 pandemic and partial lockdowns in various areas of the country.

Besides, the regulator received representations from stock brokers regarding changes to the systems and software development.

In a circular, the Securities and Exchange Board of India (Sebi) said the mechanism of pledge and re-pledge will be implemented with effect from August 1.

Trading members (TMs) or clearing members (CMs) need to align their systems and accept client collateral and margin-funded stocks by way of creation of pledge and re-pledge in the depository system.

It further said TM or CM will also be allowed to accept client securities as collateral by way of title transfer into the client collateral account as per the present system.

The system of parallel acceptance of the client securities by way of title transfer shall be available only up to August 31, 2020, and no further extension shall be granted, Sebi said.

Funded stocks held by the TM or CM under the margin trading facility will preferably be held by them by way of pledge with effect from August 1.

It further said trading or clearing member may continue to hold funded stocks in respect of margin funding in client margin trading securities account till the end of August.

The regulator reiterated that trading or clearing member will have to close all existing demat accounts tagged as client margin or collateral by August 31.

Earlier in the day, the Association of National Exchanges Members of India (ANMI) has written to Sebi and the finance ministry seeking them to consider granting extension of implementation of Sebi circular for the next two months and allow the existing system of crediting the funded stock to earmarked funded stock DP account.

In February, Sebi had issued stringent norms to prevent misuse of clients securities that are available with trading and clearing members, and depository participants.

It had banned transfer of clients securities to demat accounts of trading and clearing members.

Under the framework, TM or CM will accept collateral from clients in the form of securities, only by way of margin pledge, created in the depository system, with effect from June 1. This was extended to August 1.

Sebi said depositories should provide margin pledge for pledging clients securities as margin to the TM or CM. The latter should open a separate demat account for accepting such margin pledge, which should be tagged as client securities margin pledge account.

For the purpose of providing collateral in the form of securities as margin, a client shall pledge securities with TM, and TM shall re-pledge the same with CM, and CM in turn shall re-pledge the same to clearing corporation (CC).

The complete trail of such re-pledge shall be reflected in the demat account of the pledgor, Sebi had said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know markets Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Excerpt from:

Sebi allows acceptance of client securities as collateral by way of title transfer till August 31 - The Financial Express

Wiseguyreports.Com Publish New Market Research Report On-Covid-19 Impact on Transportation Management Systems (TMS) Market 2020 Global Analysis, Size, Share, Trends, Opportunities and Growth, Forecast 2026 Research details advancements in the Global Analysis by Key Players JDA Software, Oracle, Descartes, SAP SE

Transportation Management Systems (TMS) Market 2020

The global report discussing the factors impacting the Transportation Management Systems (TMS) market and will expand between 2021 to 2026, the forecast period. The intent of this report is to increase the chance of comprehending the global market and chart routes that, if explored, can produce a better profit margin in the coming years.

This study has a strong knowledge of the market. It encompasses a thorough understanding of service or product, a properly-chalked segmentation to inspire better decision-making procedures, regional impact, enriched supply-demand curve, support from end users, and trends that are affecting the flow of the global Transportation Management Systems (TMS) market.

Request Free Sample Report @www.wiseguyreports.com/sample-et-2019-by

Competitive Analysis:Research analysts have dug deep into the changes made by several companies in the past few years to understand how they have impacted the Transportation Management Systems (TMS) market. In the process, they have included strategic mechanisms like innovation, acquisition, better research and development facilities, merger, and others to facilitate a proper understanding of the way the market is working.

This will also help in gauging trends that can inspire the market outcome.

The top players covered in Transportation Management Systems (TMS) Market are:JDA SoftwareOracle CorporationManhattan AssociatesDescartesSAP SEBluJayTMW SystemsOmnitracsORTECHighJumpMercuryGateOne Network EnterprisesPrecision SoftwareCargoSmartNext Generation Logistics

Market Dynamics:The Transportation Management Systems (TMS) market report puts in efforts to understand various dynamics that are at play in the market. Their inter-relations are helping the market in gaining prominence.

A better understanding of it would help in forming strategies that could ensure the furthering of the market. It also includes a study of the production flow, its impact on the end user, and maintenance of the supply chain, which can boost the market understanding.Segmentation:Market reviewers of the global Transportation Management Systems (TMS) market bank on segmentation to have a profound knowledge of the market that can help in decision-making. These segments are backed by scientific approaches, factors, figures, charts, graphs, and others.

A proper analysis of the volume and value is also needed to understand how well the market can perform in the coming days.Regional Analysis:An all-inclusive region-specific analysis reveals aspects like demographic challenges that would play a prominent role in the Transportation Management Systems (TMS) market. These hindrances mostly deal with regional preferences, channelizing resources, generating demand in the market, cultural impact, investment scope, associated industries, and others.

In doing so, it takes into account aspects like a proper study of Europe and drawbacks witnessed in West and East Europe, Asia Pacific, details of both North and South America, and countries of both economic uncertainty and stability from the Middle East & Africa to mark various regional possibilities.

For Customisation and Query@www.wiseguyreports.com/enquiryet-2019-by

Table of Contents Analysis of Key Points

1 Transportation Management Systems (TMS) Market Overview

2 Company Profiles

3 Global Transportation Management Systems (TMS) Market Competition, by Players

4 Global Transportation Management Systems (TMS) Market Size by Regions

5 North America Transportation Management Systems (TMS) Revenue by Countries

6 Europe Transportation Management Systems (TMS) Revenue by Countries

7 Asia-Pacific Transportation Management Systems (TMS) Revenue by Countries

8 South America Transportation Management Systems (TMS) Revenue by Countries

9 Middle East and Africa Revenue Transportation Management Systems (TMS) by Countries

10 Global Transportation Management Systems (TMS) Market Segment by Type

11 Global Transportation Management Systems (TMS) Market Segment by Application

12 Global Transportation Management Systems (TMS) Market Size Forecast (2020-2026)

13 Research Findings and Conclusion

14 Appendix

List of Tables and Figures

Continued..

NOTE: Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

This email address is being protected from spambots. You need JavaScript enabled to view it.

Read more here:

Transportation Management Systems (TMS) Market 2020-2026 scrutinized in the new analysis - WhaTech Technology and Markets News

New Jersey, United States,- The research report on Treasury Management System (TMS) market comprises of insights in terms of pivotal parameters such as production as well as the consumption patterns alongside revenue estimations for the projected timeframe. Speaking of production aspects, the study offers an in-depth analysis regarding the manufacturing processes along with the gross revenue amassed by the leading producers operating in this business arena. The unit cost deployed by these producers in various regions during the estimated timeframe is also mentioned in the report.

Significant information pertaining to the product volume and consumption value is enlisted in the document. Additionally, the report contains details regarding the consumption graphs, Individual sale prices, and import & export activities. Additional information concerning the production and consumption patterns are presented in the report.

In a word, the Treasury Management System (TMS) Market report provides major statistics on the state of the Treasury Management System (TMS) industry with a valuable source of guidance and direction for companies and individuals interested in the market. In the end, Treasury Management System (TMS) Market report delivers a conclusion which includes Research Findings, Market Size Evaluation, Global Market Share, Consumer Needs along with Customer Preference Change, Data Source. These factors will raise the growth of the business overall.

Regions Covered in the Global Treasury Management System (TMS) Market:

The Middle East and Africa (GCC Countries and Egypt)

North America (the United States, Mexico, and Canada)

South America (Brazil etc.)

Europe (Turkey, Germany, Russia UK, Italy, France, etc.)

Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Highlights of the Report:

Accurate market size and CAGR forecasts for the period 2020-2026

Identification and in-depth assessment of growth opportunities in key segments and regions

Detailed company profiling of top players of the global Treasury Management System (TMS) market

Exhaustive research on innovation and other trends of the global Treasury Management System (TMS) market

Reliable industry value chain and supply chain analysis

Comprehensive analysis of important growth drivers, restraints, challenges, and growth prospects

The scope of the Report:

The report offers a complete company profiling of leading players competing in the global Treasury Management System (TMS) marketwith a high focus on the share, gross margin, net profit, sales, product portfolio, new applications, recent developments, and several other factors. It also throws light on the vendor landscape to help players become aware of future competitive changes in the global Treasury Management System (TMS) market.

Reasons to Buy the Report:

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage, and more. These reports deliver an in-depth study of the market with industry analysis, the market value for regions and countries, and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Originally posted here:

Treasury Management System (TMS) Market by Technology Innovations and Growth 2020 to 2027 - Bulletin Line

COLORADO SPRINGS In our last story Dr. John Fleming, MD, is a Board Certified Psychiatrist and a Distinguished Life Fellow of the American Psychiatric Association with Southern Colorado TMS Center in Colorado Springs talked about the impact of uncertainty we are all facing in regards to the pandemic right now. But how do you know if the struggles are taking an emotional toll on you and what can you do to feel better, with no end to the uncertainty insight?

If we are lucky in life, we have someone close to us who cares enough to help us be aware of how our emotions, actions, and behaviors are affecting ourselves and others, but thats not always the case.

Dr. Fleming says, Emotionally most of us are not wired that way, to automatically be able to access our feelings.

If thats not the case there are warning signs we can look for that indicate there may be a mental health issue that needs to be addressed. Dr. Fleming says ask yourself these questions, Am I sleeping all right? Am I kind of cranky? Am I doing something that is assigned to me, like overeating or under-eating or turning too much to alcohol or pot, or avoiding people or desperately interacting with people?

If the answer is yes to those negative behaviors, its important to find positive coping skills to deal with the ongoing societal uncertainty. If we can realize that we're facing an extended period of uncertainty we can realize we need to do stress management. We need to take care of ourselves each day. The way you do that - is to the extent that you can - get regular sleep, eat quality food, get regular exercise, and every day try to take some time - even if its just 10 or 15 minutes where you're not involved in the same old thing.

Finding the right activity for you depends on you. Dr. Fleming says not doing the same old thing will be different for different people. Maybe it's reading a book, maybe it's watching a video, maybe it's going for a walk and just enjoying the weather. Perhaps it's a chat with an old friend where you don't talk about current things, but you recall wonderful times together in the past. Find your bliss, and engage in it actively.

Since most of us are not in a position to come up with a vaccine for COVID-19 and fix societys problems, the only thing we do have control over is ourselves. Dr. Fleming explains, I can embrace how I really feel, I can manage my stress - those are things I can do. You may be trying and a lot of people are trying, but then they have anxiety or depression that expands. This is a good time if you already suffer from things such as anxiety, panic, depressive feelings, suicidal thoughts, to reach out and get help. Most clinicians in El Paso county are doing Zoom sessions, and some are even holding in-person sessions in rooms where people can be far enough apart.

If you have been battling anxiety and depression, and the pandemic has pushed it to new levels and the medications or therapy you have been trying are not working, it may be time to try something new, says Dr. Fleming. Here at our center (Southern Colorado TMS Center), we have unusual treatments. I called them unusual only because most people don't use them or have not heard of them, but they're medically certain. Such as the use of TMS (Transcranial magnetic stimulation) or Ketamine for people that the usual medications aren't working for. All these things are open and available. Demand for services is increasing because you don't do human beings any favors when you make life uncertain, and that's what's happened to us.

Finally, Dr. Fleming says many times a conversation with ourselves simply isnt enough, and fears or concerns about seeing a shrink shouldnt stop you from giving it a try. I've been doing this for about 43 years now, and I joke that I'm not a shrink - I'm an expander. Hopefully, the service that I provide to people is to listen to them. I don't have a stake in their life per se. If I try to talk to my wife about how angry I am, and she's having to live with me, who knows how that conversation will go? If I go to a third party such as a therapist, they will be concerned for you and your feelings. So if you're having a rough day they can relate to you without their feathers getting ruffled. That's the advantage I think of a professional conversation.

If they thought of getting counseling or professional help has ever crossed your mind, now is a good time to take that step.

Southern Colorado TMS Center is a proud sponsor of Your Healthy Family

Read the rest here:

Your Healthy Family: Getting help with the stress of uncertainty during a pandemic - KOAA.com Colorado Springs and Pueblo News

Markets regulator Sebi on Wednesday allowed co-existence of the current title transfer collateral mechanism and the new pledge and re-pledge process till August 31. The decision has been taken in view of the prevailing situation due to the COVID-19 pandemic and partial lockdowns in various areas of the country.

Besides, the regulator received representations from stock brokers regarding changes to the systems and software development. In a circular, the Securities and Exchange Board of India (Sebi) said the mechanism of pledge and re-pledge will be implemented with effect from August 1.

Trading members (TMs) or clearing members (CMs) need to align their systems and accept client collateral and margin-funded stocks by way of creation of pledge and re-pledge in the depository system. It further said TM or CM will also be allowed to accept client securities as collateral by way of title transfer into the client collateral account as per the present system.

"The system of parallel acceptance of the client securities by way of title transfer shall be available only up to August 31, 2020, and no further extension shall be granted," Sebi said. Funded stocks held by the TM or CM under the margin trading facility will preferably be held by them by way of pledge with effect from August 1.

It further said trading or clearing member may continue to hold funded stocks in respect of margin funding in 'client margin trading securities account' till the end of August. The regulator reiterated that trading or clearing member will have to close all existing demat accounts tagged as client margin or collateral by August 31.

Earlier in the day, the Association of National Exchanges Members of India (ANMI) has written to Sebi and the finance ministry seeking them "to consider granting extension of implementation of Sebi circular for the next two months and allow the existing system of crediting the funded stock to earmarked funded stock DP account". In February, Sebi had issued stringent norms to prevent misuse of clients' securities that are available with trading and clearing members, and depository participants.

It had banned transfer of clients' securities to demat accounts of trading and clearing members. Under the framework, TM or CM will accept collateral from clients in the form of securities, only by way of "margin pledge", created in the depository system, with effect from June 1. This was extended to August 1.

Sebi said depositories should provide "margin pledge" for pledging clients' securities as margin to the TM or CM. The latter should open a separate demat account for accepting such margin pledge, which should be tagged as 'client securities margin pledge account'. "For the purpose of providing collateral in the form of securities as margin, a client shall pledge securities with TM, and TM shall re-pledge the same with CM, and CM in turn shall re-pledge the same to clearing corporation (CC).

"The complete trail of such re-pledge shall be reflected in the demat account of the pledgor," Sebi had said..

View original post here:

Sebi allows acceptance of client securities as collateral by way of title transfer till Aug 31 - Devdiscourse

In Global TMS(Transcranial Magnetic Stimulation) Coil Market 2020 by Manufacturers, Type and Application, Forecast to 2025, the global market has been comprehensively analyzed and the results are presented in the market report published. The overview of the global TMS(Transcranial Magnetic Stimulation) Coil industry is extensively researched in the report. The report spotlights on market size, market share, market segmentation, significant growth drivers, and market competition. The report reveals the market revenue earned by the different companies operating in the market. The research provides a detailed breakdown of the major aspect of the companies such as financial aspects, research including development. The report analyzes each segment in the market as well as opportunities.

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

Survey of Global TMS(Transcranial Magnetic Stimulation) Coil Market:

The report delivers extensive business summary and market growth analysis and discusses chain structure, industry environment, sales channels and distribution, and contemporary trends. The report highlights the market drivers, future opportunities, and restraints. The study then introduces effective manufacturing methods, production volume, manufacturing facilities, capacities, pricing analysis, product description. In order to fulfill the requirements, the industry analysts have examined the strategic activities of the competitors to help the major players increase their competitiveness.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/79313

All the market players functioning in the global TMS(Transcranial Magnetic Stimulation) Coil market are profiled in detail in the report. The list includes all the major players along with the distributors, retailers, and suppliers information. Details of the market players MAG & More, ANT Neuro, Magstim, MagVenture, Deymed, Brain Latam Co are also incorporated in the market report. Additionally, a detailed study of business strategies for the growth of the market market-leading players has been offered within the report.

Market segmentation by product: H-coil, C-core Coil, Circular Crown Coil

Market segmentation by application: TMS(Transcranial Magnetic Stimulation) Coil has been Hospital, Clinic, Others

The study provides an in-depth overview of country-level break-up classified as potentially high growth rate territory, countries with the highest market share in past and current scenario. Some of the regional break-up classified in the study are: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia), South America (Brazil, Argentina), Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/79313/global-tmstranscranial-magnetic-stimulation-coil-market-2020-by-manufacturers-type-and-application-forecast-to-2025

Importance of the Global Market Report:

The report studies the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. Furthermore, the study includes the growth rate of the global market, consumption tables, facts, figures, and statistics of key segments. The global TMS(Transcranial Magnetic Stimulation) Coil market is segmented by component, deployment mode, organization size, industry vertical, and region. Market trends are the upward or downward movement of a market, throughout an amount of time. Market segmentation is the division of the market or population into subgroups with similar motivations.

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team (sales@marketsandresearch.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketsandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketsandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: sales@marketsandresearch.bizWeb: http://www.marketsandresearch.biz

View original post here:

Global TMS(Transcranial Magnetic Stimulation) Coil Market 2020 Industry Analysis, Size, Share, Growth, Trend and Forecast to 2025 - Red & Black...

Austin Dillon snapped a long winless streak when he won at Texas Motor Speedway last Sunday, and a statement win it was. (Photos courtesy of NASCAR)

By John Sturbin | Senior WriterRacinToday.com

FORT WORTH, Texas Austin Dillon did his pop-pop proud, and zinged his critics, after leading a 1-2 sweep for Richard Childress Racing in Sundays 24th annual OReilly Auto Parts 500 at Texas Motor Speedway.

The 30-year-old grandson of team-owner/NASCAR Hall of Famer Childress, Dillon withstood three restarts in the latter stages of the 334-lap NASCAR Cup Series race while battling rookie teammate Tyler Reddick and Cup champions Joey Logano of Team Penske and Kyle Busch of Joe Gibbs Racing.

Not bad for a silver-spoon kid, right? Ill take that, said Dillon, a sarcastic reference to a label put on him by Kevin Harvick during his tenure at RCR. Tyler Reddick, he raced me clean. 1-2 for RCR _ this has been coming. Weve had good cars all year (thanks to crew chief) Justin Alexander and my whole crew.

Dillons third career Cup victory snapped an 88-race winless streak and returned the No. 3 Chevrolet made famous by seven-time series champion Dale Earnhardt (six at RCR) to Victory Lane.

Way to go Austin, Im so proud of you, Childress said over Dillons in-car radio during his cool-down lap around TMS high-banked/1.5-mile oval. Dillons margin of victory over Reddick, a two-time Xfinity Series champion, was 0.149-seconds.

Dillons Cup resume includes victories in two of NASCARs premier events _ his first win in the Coca-Cola 600, NASCARs longest race, at Charlotte Motor Speedway in 2017 and the 2018 Daytona 500, NASCARs season-opening Super Bowl at Daytona International Speedway. Dillon also has nine career wins in the Xfinity Series and seven career wins in the Gander RV & Outdoors Truck Series. He is the 2011 Truck Series champion and the 2013 Xfinity Series champ.

Still, the first words out of his mouth post-race were directed at his so-called haters.

The Cup field took the green flag in front of actual live fans at TMS last weekend. How many fans? It didnt matter, TMS officials said.

Its OK, man.Sports are sports, Dillon said. You got to have someone you dont like.Maybe its just my background, where I come from.But I got a lot of people that love me, too.It doesnt bother me at all really.They can either get on the bandwagon and love meits OK.Its part of sports.Haters are going to hate sometimes, but well be all right.

Austin and younger brother Ty, the sons of RCR General Manager/former journeyman driver Mike Dillon, are the backbone of Childress family-oriented team based in Welcome, N.C. Childress, whose old-school/hardscrabble background was a perfect business match with Earnhardt, has no problem defending family.

You know, I think you get in the No. 3 car behind Dale Earnhardt, people think your granddaddy gave you this, said Childress, a 2017 NASCAR HOF inductee. He earned it no different than Ty Dillon.They had to earn their right to drive their cars.I think that may be a little bit of it.

We didnt give Austin the cars he needed (last year). Chevy has really worked hard and put together a great car for us.

Ill never forget 98 when Dale Earnhardt came and said, I want to retire, its me. I said, No, it isnt, Dale.We havent given you the cars.^ Cap E famously went on to win the 1998 Daytona 500 to kick-off NASCARs 50th anniversary season.

Dillon took the lead from Reddick for the first time on a restart on Lap 312 following the eighth caution on Lap 308. Alexander decided to take only left side tires and fuel during that stop.

What a call by Justin, Dillon said. Lefts had freed my car up all day.I was tight.When we put the lefts on, it was the call we needed to go on and win the race. I mean, Justins done a great job all year of putting us in good positions when it comes to track position.All three of my Cup wins are with Justin.Love the guy.I cant thank him enough for everything hes done for me and my family. Hes been putting great products out there.

He deals with me.Im not the easiest individual in the world to deal with.I can get cranky from time to time.Its just because Im passionate and Im a grinder.I feel like I can go out there and compete week and week out with these guys. This was a huge win for our company, RCR, ECR, everybody that supports us.It was really cool. It was nice to also have the ball in my court, to dictate the end of the race.

Caution No. 9 flew on Lap 320 and No. 10 was waved on Lap 330. The RCR teammates held serve on the final restart on Lap 332 as former series champions Logano and Busch squabbled for third with the former rounding out the podium.

Yeah, I had to change it up a couple of times, said Dillon, driver of the No. 3 Bass Pro Shops/Tracker Off Road Camaro ZL1 1LE. Definitely had to earn it. I changed it up. I waited the second one and I went on the last one. So, it worked out for me good.

Dillon led twice for a total of 22 laps, including the last 10. Reddick also led twice, for five laps. Dillon and Reddick, 24, gave RCR its first 1-2 Cup finish since Clint Bowyer and Jeff Burton placed 1-2 at Talladega Superspeedway in 2011 for the organizations 109th win.

What a great day for Richard Childress Racing, said Reddick, driver of the No. 8 Cat Oil & Gas Camaro overseen by crew chief Randall Burnett. This organization is working so hard and to have a 1-2 finish like we did is incredible. We really couldnt ask for much more than what we got today. One spot better would have been great, but the recovery this team made today was huge. Were racing for the big picture of making the Playoffs, so we have to race smart. Days like this will help us get there.

Reddick is 17th in points, 12 behind William Byron and the No. 24 Axalta Chevy fielded by Hendrick Motorsports for the 16th and final Playoff qualifying position with eight regular season events remaining.

Sundays victory secured Dillon a spot in NASCARs 10-race postseason Playoffs that includes the AAA Texas 500 weekend here Oct. 24-25.

Next up on a Cup schedule revised because of the COVID-19 pandemic is Thursday nights Super Start Batteries 400 Presented by OReilly Auto Parts at the 1.5-mile Kansas Speedway. NBC Sports Network will televise the 267-lapper at 7:30 p.m. (EDT) with radio coverage on MRN and SiriusXM Channel 90.

There has been no practice or qualifying in NASCARs three national touring series since the sports return at Darlington Raceway on May 17. On Wednesday, NASCAR announced the remainder of the 2020 season will continue to operate under that procedure.

The current format has worked well in addressing several challenges during our return to racing, Scott Miller, NASCAR Senior VP, Competition, said in a statement. Most importantly, we have seen competitive racing week-to-week. NASCAR will adjust the starting lineup draw procedure for the Playoff races and will announce the new process at a later date. Miller said this decision was made after discussions with our race teams and the broader industry, certainly including NBC Sports Group.

Dillon was treated for dehydration post-race via a couple IVs in the TMS infield care center. He and his peers battled extreme temperatures during the 501-miler that included a red flag stoppage of 11 minutes, 29 seconds after a grinding, 12-car crash along the front stretch on Lap 220. Ambient temperatures reached 96 degrees with a sauna-like heat index of 102-105 inside the cockpit.

That didnt deter Logano and Busch from pressing the RCR teammates down the stretch. Logano, the 2018 Cup champion, finished third in his No. 22 Shell Pennzoil Ford Mustang. Busch, the two-time/reigning Cup champ, finished fourth in the No. 18 Interstate Batteries Toyota Camry.

Harvick, the series point leader and winner of four races this season, placed fifth in the No. 4 Mobil 1 Ford fielded by Stewart-Haas Racing. Harvick exited Texas with a 91-point lead over Ryan Blaney of Team Penske. Blaney won the first two stages and led a race-high 150 laps in his No. 12 Menards/Maytag Ford en route to a seventh-place finish.

Sundays race was the first major sporting event conducted in Texas with fans in attendance since the onset of the COVID-19 pandemic in March, when this race originally was booked. Under guidelines issued by Gov. Greg Abbott, TMS was allowed to accommodate up to 50 percent of its listed capacity of 135,000, including suites.

TMS President/General Manager Eddie Gossage continued to be coy when asked to provide a crowd estimate Sunday. But during an in-race interview in the Press Box, Gossage said he would not be offended if the crowd count was listed somewhere between 15,000 and 20,000.

These are the folks that want to be here, said Gossage, wearing a face mask. We never were trying to set an attendance record. I told yall (media) that youre going to turn on the TV and go, Nobodys there! And the truth is theres a pretty good number here. But still, its a massive place. I was downstairs when they opened the gates and everybody seemed happy and everybody had masks on and was distancing.

Dillon parked the nose of his Camaro against the front stretch wall near the starters stand and celebrated with an extended burnout directed at the fans. Felt really good.I think it would have been awkward without them, Dillon said. Thats why I parked it right in front of them and let them smell that smoke, the burnt rubber.Everything I did was for those fans.I think they loved it.

I also gave the (checkered) flag away to a little kid.He had a Kyle Busch shirt on.I told him he needed to get a new shirt.Hopefully, I transferred him over.

Read the rest here:

Racin' Today Dillon Answers 'Haters' With Victory In Texas - RacinToday.com

Depression is a growing problem in Canada and elsewhere, and one of the most important public health issues today, says the World Health Organization (WHO). The COVID-19 pandemic and the ensuing containment measures have had an impact on the mental health of Canadians and have created conditions that are associated with increased rates of suicide.

Unfortunately, front-line treatments for depression, such as psychotherapy and medication, remain ineffective for a large portion of patients receiving care.

However, a new type of treatment is promising: neurostimulation. Here, a technician in a clinic directs a magnetic coil and delivers a few hundred electromagnetic pulses to a specific area of the brain. Treatments are painless, involve no surgery or significant side-effects and take less than an hour a day. The results are impressive. But is this too good to be true?

As a professor of neuroscience in the department of biology at the University of Ottawa and an affiliated researcher at the Krembil Research Institute in Toronto, my research in nonlinear physics has led me to the incredible complexity and richness of biological systems, especially in neuroscience.

Using mathematics and the power of numerical computation, it is possible to better understand not only how the brain works at the cellular level but also how its vast network is organized and what may be lacking because in presence of diseases, such as depression. This can help identify new avenues for treatment and test their effectiveness through simulations. Its a huge task that Im working on in collaboration with an interdisciplinary team of researchers around the world.

During the past decade, medical treatments involving neurostimulation, or cerebral electromagnetic stimulation, have resurfaced in neuroscience and psychiatry.

After the murky days of electroconvulsive therapy and other techniques, which had rather bad press, electrical or magnetic stimulation of neurons is attempting a comeback, using a much more sophisticated approach and much lower electrical currents. As a result, neurostimulation is becoming increasingly important in the treatment of depression, and its effectiveness seems to surpass that of medication in many patients.

Methods such as transcranial magnetic stimulation (TMS) are safe and painless alternatives to traditional pharmacological treatments. In addition, they have virtually no side-effects and offer new insights into the manipulation and control of cognitive processes.

Recent meta-analyses have identified positive and lasting effects of TMS neurostimulation treatments on patients with depression, some of whom experienced benefits up to one year after treatment.

These treatments are now approved by many regulatory agencies and the clinical use of neurostimulation is on the rise in many countries. In particular, portable TMS devices are in development and in the process of being approved by Health Canada for wider, accessible deployment. These devices would allow patients to treat themselves at home, without having to go to the clinic every day as is currently the case.

However, a major challenge remains: how to control brain activity accurately. What areas and types of magnetic signals should be used to relieve patients symptoms? For despite amazing results and promising advances, the mechanisms of neurostimulation remain poorly understood. Why?

TMS uses a coil to create a magnetic field that induces electric currents in the brain. Neurons are cells that communicate by means of repeated electrochemical impulses; the brain is an organ with essentially electrical functions. Magnetic fields can therefore influence the dialogue between different areas of the brain and in theory restore or balance their function.

The brain, composed of billions of neurons with continuously changing dynamics, is an incredibly complex network. Neurostimulation therefore poses quite a problem for researchers and clinicians, such as where to stimulate and how. The problem is so great that many advances are being made empirically using the trial-and-error method.

Mathematics is involved in this interdisciplinary adventure. What if, through mathematical models of brain circuits, we could understand how stimulation influences neurons and how its effects propagate?

By integrating brain imaging data such as magnetic resonance and electroencephalograms, mathematics can be used to create numerical simulations to better understand the influence of neurostimulation on neuronal activity. Its a promising approach that could indeed allow us to unravel the mystery of considering the brain as a pendulum!

To better understand, lets go back a bit.

The activity of neurons in the brain is far from being random and irregular. On the contrary, the neurons in certain parts of the brain co-ordinate their activity and react at the same time. They synchronize. This synchronization of the neurons in the brain appears in the magnifying glass of medical imaging as waves, or very characteristic oscillations, which are also called brain rhythms.

Brain activity oscillates like a pendulum and this constant to-and-fro movement allows us to see neuronal processes in action. Like ripples on a pond, brain rhythms are dynamic, changing according to our cognitive states. They will be different during a sustained mental effort, during physical activity and during sleep or meditation.

Researchers believe that brain waves are involved in the majority of brain processes. It is also these same rhythms that seem to be lacking in many neurodegenerative diseases. They are absent, too strong or too slow.

What if we could control these rhythms with the help of neurostimulation? This is the emerging hypothesis put forward by some neurostimulation researchers. Using advanced mathematics and computer simulations, they want to understand how co-ordination between networked neurons can be influenced and to what extent electromagnetic stimulation can be used to control brain rhythms and to develop treatments for neurological disorders such as multiple sclerosis, Parkinsons, schizophrenia and depression.

This research may lead to a better understanding of the role of these rhythms in brain function, the code used by neurons to communicate with each other and a better understanding of what is lacking in certain diseases. It may also allow us to use neurostimulation to increase the computational capacity of these neural networks, thereby increasing cognitive abilities and creativity. Science fiction? Maybe but not completely.

See the original post:

Neurostimulation may herald a new treatment for depression - The Conversation CA

The country's FA has been at loggerheads with the league over the restart of the season but the current campaign may go on beyond August 31

The South African Football Association (Safa) has received a response from Fifa advising them that they have the powers to extend the date of completion of the 2019-20 PSL season.

In a statement releasedon Wednesday, Safa said the season can be extended in terms of the Transfer Management System (TMS).

This means the suspended season can go beyond theAugust 31 deadline set by the PSL.

"The world football governing body, Fifahas written to the South African Football Association (Safa) advising them that they can extend the completion of the current Premier Soccer League season in terms of the Transfer Management System (TMS)," reads the statement.

Furthermore, Fifa mandatedSafa to amend the start of the upcoming season as well as the registration of new players.

"In the same context, Fifahas given Safathe mandate to amend the start of the PSL next season (2020/2021) and this may require the Association to amend the registration periods provided in the TMS."

Safa published part of the statement as sent to them by Fifa, and it reads as follows:

"As such, the association concerned should extend the end date of the ongoing season in the TMS, to reflect the match schedule. This may also require the association to amend the registration periods provided in the TMS."

Safa acting CEO Tebogo Motlanthe said the association was pleased with the clarification from Fifa and assured the country that the referees will be ready come August 1.

"We are glad with the clarification we got from Fifaand we have already started preparation of the referees. They will arrive at the camp in batches and I want to assure everyone that the match officials will be ready, come 1 August 2020 when the PSL kicks off,"said Motlanthe.

Last week, Safa rejected PSL's proposed return date of July 18, stating that the match officials were not ready and fit enough to complete the season.

The country's FA further resolved that referees be mandated to a 14-day fitnessand medical tests, a compromise on their side as Fifa requires match officials to undergo a three-week intense training programme before they can be deemed ready to resume work.

Safa offered to cover the costs of the 110 match officials which includeaccommodation, transportation and the conducting of tests.

Article continues below

It is unclear at this stage if the PSL will accept Safa's proposed return date of August 1 but the league said in its response that Dr Irvin Khoza would re-engage all the stakeholders on the association's position.

Weekendreports suggested the PSL was considering cancelling the campaign as it feels it would not have enough time to playthe remainingof the matches.

The league is expected to hold a board of governors meeting this week to plot the way forward for the current season which has been suspended since mid-March.

Read the rest here:

Coronavirus: Fifa gives Safa the power to extend the 2019-20 PSL season - Goal.com

People with treatment-resistant depression have been driving from Salem to Tigard for their special therapy sessions. In August, they can skip the long trip and get the care they need in south Salem.

Dr. Jonathan Horey, cofounder and chief medical officer, Active Recovery TMS. (Submitted photo)

People with depression that isnt easily treated soon won't have to drive for hours to access an innovative, FDA-approved therapy option.

On Aug. 3, Active Recovery TMS will open a new clinic in south Salem.

The Boulder Creek Clinic, located at 2525 12th St. S.E., will treat up to 40 patients per day when running at full capacity.

Active Recovery TMS currently has locations in Hillsboro, Portland and Tigard. Dr. Jonathan Horey, cofounder and chief medical officer, said Salem has long needed such a treatment facility. He noticed Salem patients driving to his Tigard location for care.

"Treatment is five days per week, and while each session lasts only 20 minutes, you have to drive there no matter how long the treatment sessions last," he said. "Our main motivation is to offer the treatment to those that don't have access yet."

TMS, or transcranial magnetic stimulation, was FDA approved for treatment-resistant depression in 2008. Medicare, Medicaid, and almost all commercial insurance plans cover TMS for major depressive disorder.

Even so, it's difficult for people with depression to find help in Oregon, Horey said.

Horey started Active Recovery with his brother in 2017, when he couldn't find a provider for a patient struggling with longstanding depression. His patient had tried 12 different medications, and he worked with Horey in weekly therapy sessions for three years with no improvement.

Horey wanted to help, and a business was born.

"He was my motivation to start this business," Horey said. "I didn't expect it to turn into this, but I'm really glad it has. It's been really nice to see what a great option it's been for people."

TMS uses electromagnetic pulses to stimulate the dorsolateral prefrontal cortex, located on the left side of the head, right beneath the skull.

"That area of the brain has been shown to be less active in people with depression. So the idea with TMS is that we're trying to wake that area up and get it functioning the way it should. And once it's functioning, you don't need stimulation to keep it going," Horey said.

Treatment starts with an hour-long mapping session. Detailed notes guide future sessions, so technicians know just where to place the equipment, how much power to use, and how long each session should last. Weekly touchup sessions with doctors ensure that the therapy stays on track.

Therapy sessions don't hurt, Horey said, but they can be uncomfortable.

"What I always tell people is that I've tried it myself, because I wanted to see what it felt like. The best way I can describe it is 'strange.' It's a strange feeling but it's not painful. If it's painful, we can adjust it so it's not," he said.

Electromagnetic pulses can cause scalp muscles to twitch. Patients sometimes feel like they're being tapped on the head by an invisible hand, and some start to panic at the sensation. But most get used to it.

"I can count on one hand the number of patients that just couldn't tolerate it, and we've treated close to 300 now," he said.

TMS sessions compliment, but don't replace, conventional depression treatments such as therapy and medication.

Conventional treatments, including counseling, won't be available at the Salem clinic for now.

"The reason we've done that is that we want to offer this therapy as a way of helping providers and patients. We pride ourselves on working closely with providers. We're in regular communication with them, and we're just supplementing their meds and the therapy they're using," he said.

Horey said his patients often benefit from his treatment sessions. Most feel better in about three to five weeks. And most complete their TMS therapy in about nine weeks.

"The great thing about TMS is that we're treating people that have not had any success with those therapies. They've gone years feeling badly," he said. "To help them feel better in the course of six to eight weeks is, I hate to say miraculous, as it seems dramatic, but to them it certainly seems that way."

He said determining the success of his treatments is easier during the pandemic. When his patients report improvement, he's more likely to believe them.

"If you can feel really good during this time, with everything going on in the world, I'm pretty confident that you're getting better," he said.

Horey said he understands that some patients are leery of starting a new treatment during the current Covid outbreak.

"It's very hard for people right now, during a pandemic, to make decisions about what's most important. 'Do I stay inside and not expose myself to Covid, or do I get treated for mental health?' I would say those are not mutually exclusive," he said. "I would encourage people not to neglect their mental health."

The Salem staff will wear masks and gloves for appointments. All equipment will be sterilized between patients. And temperature checks will be performed before entry. Social distancing guidelines will be followed, too.

To make an appointment, call (503) 683-8438. No referrals are required.

Contact Salem Reporter with a news tip, story idea or question by email at [emailprotected]

SUPPORT ESSENTIAL REPORTING FOR SALEM- A subscription starts at $5 a month for around-the-clock access to stories and email alerts sent directly to you.Your support matters.GoHERE.

Read the original:

For those in Salem with depression, new clinic provides another resource for treatment - Salem Reporter

Penn Medicine: Launching the Regions First Center for Translational Neuromodulation

The brain is one of the most complex systems in the body, controlling movement, memory, communication, emotion, thought, and more. Unfortunately, serious diseases and injuries such as stroke, dementia, and psychiatric disorders can impede and disable core functions in the brain. Now, thanks to recent advances in neuroscience, neuroengineering, and other converging fields, experts are exploring the use of neuromodulationnoninvasive brain stimulationto restore these functions in the brain, and Penn Medicine has launched a new center to study this science.

The Penn Brain Science, Translation, Innovation, and Modulation (brainSTIM) Center brings together a team of leading neuroscientists, neurologists, psychiatrists, psychologists, and engineers at Penn using neuromodulation techniques to research, repair, and enhance human brain functionthe first translational center of its kind in the region.

The brainSTIM Center is being led by Roy Hamilton, an associate professor of neurology and physical medicine and rehabilitation at the Perelman School of Medicine at the University of Pennsylvania. The center will be a hub for developing new treatments that use neuromodulationdirect stimulation of the brain with electrical signals or magnetsto reorder, reorganize, and restore brain function in patients suffering from various types of neurological disorders such as dementia and stroke and psychiatric disorders like anxiety.

Neuromodulation is a fascinating technologyits already successfully used to treat depression and weve led exciting research on brain stimulation and aphasia, a language disorder which impairs a persons ability to communicate. But this is just the tip of the iceberg, said Dr. Hamilton. Our driving goal is to investigate how cognition works in the neural networks of the brain, uncover how to enhance those functions, and ideally develop new simulation-based therapies for our patients.

The center uses a range of neuromodulation tools, including transcranial magnetic stimulation (TMS), and transcranial electrical stimulation (tES) techniques. By combining these technologies with advanced imaging tools, such as structural and functional magnetic resonance imaging, experts can explore key structure-function relationships in the brain that underlie human cognition and neural function.

Dr. Hamilton and fellow brainSTIM faculty members Branch Coslett, William N. Kelley Professor of Neurology, and John Medaglia, adjunct assistant professor of neurology at Penn and an assistant professor of psychology at Drexel University, are pursuing work funded by the National Institute on Deafness and Other Communication Disorders and the Department of Defense to determine whether transcranial direct current electrical stimulation (tDCS) of the brain can be used to slow the progression of language loss for those with primary progressive aphasia (PPA), a neurodegenerative condition that impairs communication ability.

Recent work from a team led by brainSTIM faculty Ted Satterthwaite, assistant professor of psychiatry, has shown that the functional networks of the brain responsible for self-control are highly variable in youth brain anatomy. They found that these networks are sculpted as adolescents develop into adulthood and are associated with individual differences in cognition. These personalized networks could be used to target neuromodulatory therapies in the developing brain.

Additionally, brainSTIM faculty Desmond Oathes, assistant professor of psychiatry, Danielle Bassett, J. Peter Skirkanich Professor of Bioengineering, and Dr. Satterthwaite are currently pursuing work funded by the National Institute of Mental Health to understand how TMS might improve working memory in healthy adults and those with ADHD by combining network control theory (a set of concepts and principles employed in engineering), magnetic stimulation of the brain, and functional brain imaging.

Over the past 20 years Ive witnessed remarkable advances in the ability of neuromodulation to influence brain circuits that drive functions, cognition, and behavior, added Dr. Hamilton. While these initiatives, and many others, are already underway at Penn, our hope is that the creation of the center will allow for even more collaboration and advancements, enabling us to provide more effective treatment options to our patients in the region and beyond.

For more information about the brainSTIM Center, visit https://www.med.upenn.edu/brainstimcenter/

Continue reading here:

Penn Medicine: Launching the Region's First Center for Translational Neuromodulation - UPENN Almanac

The South African Football Association (Safa) has received a response from Fifa advising them that they have the powers to extend the date of completion of the 2019-20 PSL season.

In a statement releasedon Wednesday, Safa said the season can be extended in terms of the Transfer Management System (TMS).

This means the suspended season can go beyond theAugust 31 deadline set by the PSL.

"The world football governing body, Fifahas written to the South African Football Association (Safa) advising them that they can extend the completion of the current Premier Soccer League season in terms of the Transfer Management System (TMS)," reads the statement.

Furthermore, Fifa mandatedSafa to amend the start of the upcoming season as well as the registration of new players.

"In the same context, Fifahas given Safathe mandate to amend the start of the PSL next season (2020/2021) and this may require the Association to amend the registration periods provided in the TMS."

Safa published part of the statement as sent to them by Fifa, and it reads as follows:

"As such, the association concerned should extend the end date of the ongoing season in the TMS, to reflect the match schedule. This may also require the association to amend the registration periods provided in the TMS."

Safa acting CEO Tebogo Motlanthe said the association was pleased with the clarification from Fifa and assured the country that the referees will be ready come August 1.

"We are glad with the clarification we got from Fifaand we have already started preparation of the referees. They will arrive at the camp in batches and I want to assure everyone that the match officials will be ready, come 1 August 2020 when the PSL kicks off,"said Motlanthe.

Last week, Safa rejected PSL's proposed return date of July 18, stating that the match officials were not ready and fit enough to complete the season.

The country's FA further resolved that referees be mandated to a 14-day fitnessand medical tests, a compromise on their side as Fifa requires match officials to undergo a three-week intense training programme before they can be deemed ready to resume work.

Safa offered to cover the costs of the 110 match officials which includeaccommodation, transportation and the conducting of tests.

It is unclear at this stage if the PSL will accept Safa's proposed return date of August 1 but the league said in its response that Dr Irvin Khoza would re-engage all the stakeholders on the association's position.

Weekendreports suggested the PSL was considering cancelling the campaign as it feels it would not have enough time to playthe remainingof the matches.

The league is expected to hold a board of governors meeting this week to plot the way forward for the current season which has been suspended since mid-March.

Go here to see the original:

Coronavirus: Fifa gives Safa the power to extend the 2019-20 PSL season - Yahoo Sports

COLORADO SPRINGS Are you feeling more stressed out than usual these days? If youre not, chances are someone close to you is. Do you believe wearing a mask is important? Do you think government leaders are making the right decisions for your best interest? Should we be sheltering in place or getting back to normal? No matter how you feel about any of these questions, chances are we are all facing one common emotion.

Dr. John Fleming, MD, is a Board Certified Psychiatrist and a Distinguished Life Fellow of the American Psychiatric Association with Southern Colorado TMS Center in Colorado Springs.

Dr. Fleming says he and his practice are keeping busy these days. I have seen both more people having depression and anxiety, and I'm seeing patients I have been working with for some time, having more intense symptoms that they're trying to manage.

The push and pull of the pandemic is creating so many challenges, says Dr. Fleming. How do I put food on my table? Do I choose to send my kids to school? Do I choose to keep my kids at home.?

During the early stages of the shutdown, Dr. Fleming says he joked with close friends that in some ways, the COVID-19 pandemic was worse than a zombie apocalypse. You can't tell who's got what. You can't tell who is sick, or how sick they'll be, you can't tell how much of a personal risk you have. Is it safe to be around my grandchildren? Could I see them at the end of the driveway? Are they welcome to come into my home, should I hug them?

No matter how you feel about any of the current issues, Dr. Fleming says we should all know that no one knows when life will get back to normal. We can look at experts, but we all know that none of the experts - whether their economic experts or public health experts - they all have a point of view but we all know none of them have a crystal ball, we all know they're guessing. Not random guesses, they're guessing based on what they know, but where does that leave us? Uncertain.

As the old saying goes, not knowing is the worst part. Uncertainty is really hard for us as human beings and right now things are uncertain, economically, politically, socially. What are we supposed to do to protect our health, to protect our children? There are school thoughts - everything is uncertain, and there are no easy answers right now.

And that uncertainty opens many of us open to deeper waters says Dr. Fleming. This is a recipe for making any of us anxious, depressed, upset, and angry.

If that mix of feelings and emotions are ignored or left to simmer, Dr. Fleming says, It's worse if we don't acknowledge the uncertainty and the fear. If we're trying to avoid uncertainty, that's when we get into conflict and that is what can make people so angry.

If you're having trouble facing or processing your own emotions right now, Dr. Fleming says the first place to start is acknowledging them - even if its simply to yourself. If you embrace the uncertainty, and say, I'm uncertain, you're uncertain let's make the best of this we can. I'm scared if you do that - that'll impact me this way. If you have that attitude, you're less likely to snap. If on the other hand, you're spending all your time and energy saying, this is right, that is wrong, this is scary and this one's safe - if we divide from each other then when something else happens things can escalate very quickly. It'll be a snap - and then a blaze - and then a fire.

In our next story, Dr. Fleming will talk about specific things we can do to recognize we are more stressed out, and things we can all do that may sound simple but if you take the time to implement them in your life - can bring a new measure of peace to your life.

Southern Colorado TMS Center is a proud sponsor of Your Healthy Family

Read the original:

Your Healthy Family: The reason so many people are stressed out right now - KOAA.com Colorado Springs and Pueblo News

COVID-19 Updates We will be covering the overall impact of COVID -19 on the market value, market share & growth of the market and how the major players in the particular market are adapting these changes.

MarketResearchBazaar has added latest research report on Global TMS(TRANSCRANIAL MAGNETIC STIMULATION) COIL Market, this report helps to analyze top manufacturers, regions, revenue, price, and also covers Industry sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

The global TMS(TRANSCRANIAL MAGNETIC STIMULATION) COIL market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2026, growing at a CAGR of XX% between 2019 and 2026.

Download Premium Sample of the Report: http://marketresearchbazaar.com/requestSample/46657

Global markets continue to sink as the coronavirus spreads, reaching over 200 countries in total by the end of March. Now the outbreak continued to grow, as the number of cases in USA, Italy, Spain, Germany, France all spiked, Europe and USA have now become the epicenter of the outbreak, Cases in China appear have steadied in April, but theres growing concern about the overall impact to the global market. This study analysis was given on a worldwide scale, for instance, present and traditional TMS(TRANSCRANIAL MAGNETIC STIMULATION) COILgrowth analysis, competitive analysis, and also the growth prospects of the central regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from sales, revenue and consumption. A quantitative and qualitative analysis of the main players in related regions is introduced, from the perspective of sales, revenue and price.

According to Research, the global TMS(TRANSCRANIAL MAGNETIC STIMULATION) COIL market was valued at USD xxx million in 2019, and it is expected to reach a value of USD xxx million by 2026, at a CAGR of xx% over the forecast period 2021-2026. Correspondingly, the forecast analysis of TMS(TRANSCRANIAL MAGNETIC STIMULATION) COIL industry comprises of Asia, North America, South America, Middle East and Africa, Europe, with the sales and revenue data in each of the sub-segments.

At the upcoming section, this report discusses industrial policy, economic environment, in addition to the fabrication processes and cost structures of the industry. And this report encompasses the fundamental dynamics of the market which include drivers, opportunities, and challenges faced by the industry. Additionally, this report showed a keen market study of the main consumers, raw material manufacturers and distributors, etc.

In order to stop the spread of the COVID-19 outbreak, countries and world capital have been put under strict lockdown, bringing a total halt to major industrial production chains. It has caused supply chain disruptions for nearly three-quarters of U.S. companies, and in the second quarter, domestically consumption is likely to be hit even harder. The same situation also appeared in Europe, as the epidemic has required large-scale restrictions on the movement of people, investment, consumption and exports will all be strongly impacted by the epidemic, domestic production and consumption will plummet in the first half of 2020. We expected a U-shaped recovery in the second half of the year in USA and Europe market.

China, Japan, South Korea, India, and other Asia countries took the lead in introducing unprecedented measures to contain the virus, the market confidence in Asia-Pacific region is returning, EU and USA have relaxed its fiscal rules with maximum flexibility, this will stimulate the market demand in the second half of 2020.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of TMS(TRANSCRANIAL MAGNETIC STIMULATION) COIL in these regions, from 2014 to 2026 (forecast), covering

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

South America (Brazil, Argentina, Columbia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Global TMS(TRANSCRANIAL MAGNETIC STIMULATION) COIL market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer, the top players including

MAG & More

Magstim

MagVenture

ANT Neuro

Brain Latam Co

Deymed

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

H-coil

C-core Coil

Circular Crown Coil

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of TMS(TRANSCRANIAL MAGNETIC STIMULATION) COIL for each application, including

Hospital

Clinic

Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Enquiry Before Buying: http://marketresearchbazaar.com/enquiry/46657

Major Point of TOC:

Chapter One: TMS(TRANSCRANIAL MAGNETIC STIMULATION) COIL Market Overview

Chapter Two: TMS(TRANSCRANIAL MAGNETIC STIMULATION) COIL Market Segment Analysis by Player

Chapter Three: TMS(TRANSCRANIAL MAGNETIC STIMULATION) COIL Market Segment Analysis by Type

Chapter Four: TMS(TRANSCRANIAL MAGNETIC STIMULATION) COIL Market Segment Analysis by Application

Chapter Five: TMS(TRANSCRANIAL MAGNETIC STIMULATION) COIL Market Segment Analysis by Sales Channel

Chapter Six: TMS(TRANSCRANIAL MAGNETIC STIMULATION) COIL Market Segment Analysis by Region

Chapter Seven: Profile of Leading TMS(TRANSCRANIAL MAGNETIC STIMULATION) COIL Players

Chapter Eight: Upstream and Downstream Analysis of TMS(TRANSCRANIAL MAGNETIC STIMULATION) COIL

Chapter Nine: Development Trend of TMS(TRANSCRANIAL MAGNETIC STIMULATION) COIL (2020-2029)

Chapter Ten: Appendix

Read Full Report: http://marketresearchbazaar.com/requestSample/46657

If you have any special requirements, please let us know and we will offer you the report as you want.

About (Market Research Bazaar):

Market Research Bazaar (MRB)- a part of VRRB Reports LLP is an overall Market Research and consulting organization. We give unparalleled nature of offering to our clients present all around the world crosswise over industry verticals. Market Research Bazaar has aptitude in giving profound jump showcase understanding alongside advertise knowledge to our clients spread across over different endeavours.

Media Contact:

UK: +442070973908

US: +13156360953

India: +919548234540

Email:[emailprotected]

Website:http://marketresearchbazaar.com/

Blog:http://marketresearchbazaar.com/blogs

Follows to Twitter : https://twitter.com/BazaarMrb

Follows to Linkdin : https://www.linkedin.com/company/market-research-bazaar-vrrb/

See the original post here:

Global TMS(TRANSCRANIAL MAGNETIC STIMULATION) COIL Market 2020 to 2025: Industry Scope of the Research - Jewish Life News

Billy C. MIlhouse to Regenal Jamison, Portion of TMN 0113-13-13-006.000, Liberty Township, $8,000.

Roy Emerson Senn to Patricia Ann Vier, TMN 0324-10-01-002.005, $10 in hand.

Barney M. Houser to Shirley Adams, Portion of TMS 0143-12-05-004.000, $12,000.

Courtyard Group, LLC to Beverly Parler Rice, TMN 0151-20-04-034, City of Orangeburg, $5 and other valuable consideration.

William P. Wooten, Trustee of the William P. Wooten Revocable Trust Agreement, dated July 23, 2015 to Jai Lanbajathara, LLC, TMS 0173-13-33-001, City of Orangeburg, $5 and other valuable consideration.

America IRA, LLC fbo John R. Payne, Traditional IRA to Harold Anthony Oliver and Christina Ann Oliver, Part of TMS 0299-00-02-001.000, $24,000.

Steve Melan to Christopher Alan Logsdon, TMS 0330-00-05-018.000,$109,000.

Joseph E. Horger and Charles F. Horger to Harry Fanning, TMN 0125-19-04-004.000, $20,000.

Thomas Mack to Howard Stokes and Karen Stokes, TMS 0282-11-06-003.000, $5.

Dwight L. Varnum and Juliet E. Streaty-Varnum to Cameron B. Proper and Victoria L. Proper, TMS 0142-15-02-016.000, Limestone Township, $286,000.

Lesli B. Darwin to Tavarus Kennerly, TMN 0066-00-02-102.000, $1,250.

Helen P. Griffith to Lewis Joe Welch and Carrie Ann Welch, TMN 0282-00-03-001, Elloree Township, $5 and other valuable consideration.

Darrell H. Johnson to Cody V. Johnson, TMS 0126-00-05-020.000, Zion Township, $5 and other valuable consideration.

Hillview Properties, LLC to Opulent-One Group, LLC, TMS 0173-16-10-009, Orange Township, $17,000.

Daniel Lingham to Kembalina Duggins, TMS 0253-00-02-018.000 and 0253-00-02-014.000, Cow Castle Township, $5 and division of property.

Harve Mobley, III and Julie Mobley to Melissa M. Tiemeyer, TPN 0150-07-00-003.000,

Milledge J. Holstein to William D. Bramlett and Brenda Bramlett, Tax ID No: 0100340, Town of North, $126,000. $375,000.

Bobby Jamison, Sr. to Sammy Jones and Alison Jones, TMS 0070-00-02-011.000, Liberty Township, $10,000.

Don Thomas Lee to Samuel E. Blakely, Sr. and Joey Blakely, TMN 0361-14-04-002.000, $25,000.

Lynn W. Sweatman to Aaron Bubba Sweatman, TMS 0357-08-01-015, $5 and other valuable consideration.

Sheryl M. Davis, Robin M. Leitch, Cynthia M. Blakeney and Elizabeth M. Newman to Nettie D. Martin, TMN 0151-12-05-015, City of Orangeburg, $5, love and affection.

Nettie D. Martin, by Sheryl M. Davis, Attorney in Fact, to Betty Cartrette Smith, TMN 0151-12-05-015.000, City of Orangeburg, $5 and other valuable consideration.

Betty C. Smith aka Betty Cartrette-Smith to Leon Dykes, TMS 0151-05-03-007.000, $5 and other valuable consideration.

Rebecca L. Pitman to David W. Hanson and Catherine M. Hanson, Tax Parcel # 0012-11-02-008.000, Town of Springfield, $49,000.

Woodrow Chance Holman, III to Russell N. Hewitt, Jr., TMN 0345-20-01-008, $5 and other valuable consideration.

Tommy M. Stillinger to New Life in Christ Church, a portion of TMS 0067-05-01-001.000, Town of North, $14,000.

One Oak Holdings, LLC to Adjoy G. Chakrabarti and Sukla Chakrabarti, Portion of TMN 0233-00-02-018.000, Middle Township, $80,000.

Helen Stewart to Thomas Bauldrick and Rossie Bauldrick,TMN 0207-07-02-013.000, $2,000.

Keneke Bell and Sabrina Bell Coleman to Leila Ann Steadman, TMN 0054-14-01-013.000, $4, love and affection.

Corrective Deed Robert H. Baker and Margaret A. White to Birt Wilson Willis and Rebecca Pait Willis, TMN 0324-13-018.000 and 0324-13-03-047.000, $145,000 and no other valuable consideration.

Reality Investments, LLC to FSA REO, LLC, Holly Hill Township, $60,000.

Joanne Schneider to Margaret Davis, TMS 0142-12-02-009.000, Limestone Township, $157,000.

Josuan Yamil Nieves to Philip A. Rockefeller and Jennifer R. Rockefeller, TMS 0324-16-01-016.000, Vance Township, $256,000.

Sammy Brown to Bertha Lee Howze, TMN 0255-00-02-011.000, Cow Castle Township, $5, love and affection.

Jean C. Corbett to William, Jason Corbett and Julius Gary Corbett, Tax Parcel # 0308-00-04-001.000, Vance Township, $5, love and affection.

Russell Lucas Akin and Ellen M. Akin to Michael Wise and Sandra Yvonne Wise, TMN 0324-15-01-004.000, $240,000.

Paragon Development of SC LLC to C. Daniel Development LLC, TMS 0181-12-07-003.000, $15,000.

Enock N. Gustave to Solomon Stokes and Gail J. Stokes, TMS 0182-05-12-017 and a portion of 0182-05-12-0015, Orange Township, $5 and other valuable consideration.

Michael Moorer to Randy O. Heywood and Brenda M. Heywood, TMS 0285-00-02-00-306, $5 and other valuable consideration.

Margaret L. Bailey to Richard W. Dial and Christina M. Dial, TMS 0361-13-03-016, $30,000.

Margaret Bailey and Lynn Shelton to Richard W. Dial and Christina M. Dial, TMS 0361-13-03-017, $40,000.

Connie Jennings to James L. Peeples, Sr. and Deloris Peeples, TMN 0154-15-3-071.000, Zion Township, $4,250.

Britton D. Moorer to Gregory A. Dame and Glenda R. Dame, Portion of TMS 0312-00-03-005, Providence Township, $13,740.

Gregory A. Dame and Glenda R. Dame to Tiffany D. Domingo, Portion of TMS 0312-00-03-005, Providence Township, $5.

Gregory A. Dame and Glenda R. Dame to Gregory A. Dame, II and Brittany N. Holley, TMS 0312-00-03-005, Providence Township, $5.

HKYO Holdings, LLC to Mark Gilmore and George Wells, TMS 0236-00-07-006, Middle Township, love and affection.

Shellie Baxter Kinard aka Shirley B. Kinard to Shastity Harley, TMS 0231-00-02-029.000 Portion of, Branchville Township, $5 and other valuable consideration.

Maxine E. Williams, Antoine Otis Flood, Loreatha Jenkins, Earnest Peoples, Willie E. Peoples and Ricky O. Flood, Jr. to Lakia P. Hart and Laquinn S. Hart, TMS 0168-00-07-008, Zion Township, $6,500.

Read the original here:

ORANGEBURG PROPERTY TRANSFERS - The Times and Democrat

As the release of the much-awaited Science-themed anime gets nearer, its followers are getting excited since there are a lot of things to anticipate. It was already revealed that Dr. Stone season 2 is set to feature the Stone Wars arc, and now more details about it have been disclosed.

In any case, this Japanese animation was renewed not long after the finale of the first season aired. It is clear that Dr. Stone is a big hit; thus TMS did not think twice about ordering for a second season to be made immediately.

Spoilers - What to expect

When the renewal was announced, it also provided a bit of teaser as to what can be expected in the upcoming new season of Dr. Stone. Aside from sharing about the new arc, there were also scenes that showed the lead Senku and his friends, General and Chrome, doing a fist bump.

The three also made a pact to stay and keep fighting together, perhaps, until they win over all their enemies. Now, in the latest trailer that was unveiled by TMS Entertainment earlier this month, more spoilers for Dr. Stone season 2 were shared.

In the first teaser, it was not shown who Senku and his group are set to fight, but in this new video, it was confirmed that the opponent is still Tsukasa and his empire. With the non-believers in Science as their rival, the battle has been called the Kingdom of Science! All forces advance!

It means that this will be a war that will be Science against the use of force from Tsukasas empire. Surely, Tsukasa and his army will fight using bare hands and traditional tools while Senkus team who has been preparing for this battle since season 1 will be attacking with their advanced gadgets, weapons, and simple strategies based on Science.

The first season was released with a total of 24 episodes and the same is expected for the second installment. Also, it was teased that Senku will also build a new civilization while also trying to solve the mystery of petrification. On the other hand, Tsukasa will also form a new kingdom in Stone Wars.

Release date

The exact release date for the next installment of Dr. Stone was not stated. However, based on TMS new poster, this anime is coming in January 2021. Check out the trailer below:

See more here:

'Dr. Stone' season 2 spoilers: TMS drops new teaser and here's what it revealed about Senku and the 'Stone Wars' arc - EconoTimes

July 20 FIFA has sanctioned a club in Mauritius for failing to use its Transfer Matching System (TMS).

Cercle de Joachim, has been fined more than $10,000 for failing to comply with FIFAs regulations governing the recruitment of foreign players.

In December 2019 the club recruited five footballers from teams in Madagascar but failed to use the TMS for four of those players.

The FIFA Disciplinary Committee found the Cercle of Joachim Sports Club responsible for the infringement of the relevant provisions of the RSTP related to the mandatory use of TMS for all international transfers of professional players, FIFA said in a statement.

The club now has 30 days to pay the fine and was also given a warning over future infringements.

Mauritius Football Association president Samir Sobh told the BBC: We have paid half the sum, as it represents a significant amount.

We have asked FIFA (if we could) to pay the outstanding balance in three instalments, but we are yet to receive a reply from them. This is a complicated situation where we have found ourselves in.

You know we have players who went to France, Portugal, Spain, Australia, and Canada but they have only asked for manual transfers.

For the United States, they neither ask for the manual transfer nor for the TMS.

We found this sanction very unjust as we sent FIFA all the documents to prove our good faith but we are complying to the decision.

Contact the writer of this story at moc.l1595346274labto1595346274ofdlr1595346274owedi1595346274sni@w1595346274ahsra1595346274w.wer1595346274dna1595346274

See the original post here:

Mauritius club fined for not doing the TMS paperwork - Inside World Football

Seamount Transport Services, a sister company to Mitco Global, today announces the addition of container chassis assets to its fleet. At time of writing, Seamounts fleet includes 30 Drivers and Clean Trucks, as well as the new pool of 75 chassis. The all new chassis are combo chassis and able to support both 40 and 45 trailers. They all have GPS tracking, and other key safety related elements.

Lenny Glenn, President of Seamount commented As the steamships moved away from being in the chassis business, along with industry consolidation, and with our customers using numerous steamship lines, the complexity of managing rental chassis became onerous. With our speed to market program and commitment to our customers to have goods transloaded or shipping within 48 hours of vessel release, the reduction in wait times, and touches required by our drivers made this an easy decision

In 2019 Seamount moved over 12,000 containers on and off the ports of Seattle and Tacoma. The volume is well balanced between containers being serviced at Mitcos facilities, and to importers with their own distribution centers in the Sea-Tac market. The Seamount team is great to work with, they insure we have the containers pulled in the priority we assign, and they do a great job managing and communicating, which helps minimize accessorial fees and surcharges, reports current Seamount customer.

Our drivers love these new chassis, says Jessica Lomax, Seamount Operations Manager. Eliminating the often-required chassis swaps, and the pickup or drops at multiple locations, we anticipate one additional turn per day per driver, which is huge for capacity.

Today Seamount services over 20 clients with their drayage services, including FEU, TEU and LCL shipments. The business is managed through an industry leading TMS specialized for drayage activities. All communication and tracking are reported real time, with integration to the Ports and Steamship lines. This allows for flexible reporting and integration to our clients ERP.

See the original post here:

Seamount announces addition of Chassis Assets to their Drayage Fleet - DC Velocity

DRESDEN, Germany, July 20, 2020 /PRNewswire/ -- GEMoaB, a biopharmaceutical company focused on the development of next-generation immunotherapies for hard-to-treat cancers, announced today that it has entered into a research collaboration and license agreement with Intellia (Nasdaq: NTLA), a global leader in the field of genome editing treatments.

The companies will conduct joint research to combine GEMoaB's proprietary RevCAR technology platform with Intellia's proprietary genome editing technologies to discover and develop next-generation allogeneic cellular immunotherapies for hard-to-treat cancers and inflammatory diseases. The companies will focus on immunotherapies directed against a selected number of targets.

Under the terms of the agreement, GEMoaB will receive payments for each product based on target reservation and selection, achievement of regulatory, clinical and commercial milestones as well as tiered royalties based on net sales. Intellia will lead the research collaboration, and be responsible for clinical development and commercialization.

"We are very pleased to enter into the agreement with Intellia, which is, similarly to GEMoaB, using its cutting-edge technology to develop breakthrough products for patients with a high unmet medical need," said Armin Ehninger, Ph.D., Chief Scientific Officer at GEMoaB. "Not only does the collaboration reflect the unique optionality of GEMoaB's technological platform, but it will also provide rapid clinical proof-of-concept for RevCAR, our second cellular immunotherapy platform."

Andrew Schiermeier, Ph.D., Intellia's Chief Operating Officer, added, "We are very pleased to work with the talented GEMoaB team, and believe that their RevCAR platform represents a unique and powerful advance in how we think about engineering cell therapies. We are confident that the combined power of GEMoaB's cellular immunotherapy platform and Intellia's numerous and proprietary CRISPR-based approaches to T-cell engineering will accelerate the development of unique and highly-differentiated, genome-edited products for patients with a high unmet medical need."

About GEMoaB

GEMoaB is a privately-owned, clinical-stage biopharmaceutical company that isaiming to become a globally leading, fully integrated biopharmaceutical company. By advancing its proprietary UniCAR, RevCAR and ATAC platforms, the company will discover, develop, manufacture and commercialize next-generation immunotherapies for the treatment of cancer patients with a high unmet medical need.

GEMoaB has a broad pipeline of product candidates in pre-clinical and clinical development for the treatment of hematological malignancies as well as solid tumors. Its clinical stage assets GEM333, an Affinity-Tailored Adaptor for T-Cells (ATAC) with binding specificity to CD33 in relapsed/refractory AML, and GEM3PSCA, an ATAC with binding specificity to PSCA for the treatment of castrate-resistant metastatic prostate cancer and other PSCA expressing late stage solid tumors, are currently investigated in Phase I studies and globally partnered with Bristol-Myers Squibb. A Phase IA dose-finding study of the first UniCAR asset, UniCAR-T-CD123 for treatment of relapsed/refractory AML and ALL is ongoing, UniCAR-T-PSMA against CRPC and other PSMA-expressing late-stage solid tumors, is planned to be tested in a Phase IA study initiated by H2 2020.

Manufacturing expertise, capability and capacity are key for developing cellular immunotherapies for cancer patients. GEMoaB has established a preferred partnership with its sister company Cellex, a world leader in manufacturing hematopoietic blood stem cell products and a leading European CMO for CAR-T cells, co-operating in that area with several large biotech companies.

About UniCAR and RevCAR

GEMoaB is developing rapidly switchable universal CAR-T platforms, UniCAR and RevCAR, to improve the therapeutic window and increase efficacy and safety of CAR-T cell therapies in more challenging cancers, including solid tumors as well as hard-to-treat inflammatory diseases. Standard CAR-T cells depend on the presence and direct binding of cancer antigens for activation and proliferation. An inherent key feature of the UniCAR and RevCAR platforms is a rapidly switchable on/off mechanism enabled by the short pharmacokinetic half-life and fast internalization of soluble adaptors termed targeting modules (TMs). These TMs provide the antigen-specificity to activate UniCAR/RevCAR gene-modified T-cells (UniCAR-T, RevCAR-T) and consist of a highly flexible antigen-binding moiety, linked to a peptide motif recognized by UniCAR-T/RevCAR-T. Different to UniCAR, where the CAR consists of a scFv, RevCAR uses an inert peptide attached to the CAR. RevCAR TMs consist of a highly flexible antigen-binding moiety, linked to a scFv domain binding to the inert peptide attached to the CAR of the RevCAR effector T-cell.

About ATAC

GEMoaB's platform of Affinity-Tailored Adaptors for T-Cells (ATAC) is characterized by high binding affinity to tumor antigens and lower affinity to the CD3 antigen on effector T-cells, preventing T-cell auto-activation in pre-clinical models. Safety and tolerability of the treatment are also increased by the relatively short serum half-life (60 min). The use of fully humanized antibodies reduces the risk of immunogenicity even in case of chronic dosing. Half-life extended ATACs are in pre-clinical development.

More information can be found at http://www.gemoab.com.

For further information please contactJana Fiebiger[emailprotected] Tel.: +49 351 4466-45012

Investor ContactMichael Pehl[emailprotected]Tel.: +49 351 4466-45030

Forward-looking Statements

This announcement includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of our control, that could cause actual results to differ materially from the results and matters discussed in the forward looking statements. Forward looking statements include statements concerning our plans, goals, future events and or other information that is not historical information.

The Company does not assume any liability whatsoever for forward-looking statements. The Company assumes that potential partners will perform and rely on their own independent analyses as the case may be. The Company will be under no obligation to update the Information.

Logo - https://mma.prnewswire.com/media/947610/GEMoaB_Logo.jpg

SOURCE GEMoaB

http://www.gemoab.com

The rest is here:

GEMoaB and Intellia Therapeutics Enter into Research Collaboration and Licensing Agreement on Next-Generation Cellular Immunotherapy Based on...

LOS ANGELES, United States: The report is an all-inclusive research study of the global Shockwave Therapy Device market taking into account the growth factors, recent trends, developments, opportunities, and competitive landscape. The market analysts and researchers have done extensive analysis of the global Shockwave Therapy Device market with the help of research methodologies such as PESTLE and Porters Five Forces analysis. They have provided accurate and reliable market data and useful recommendations with an aim to help the players gain an insight into the overall present and future market scenario. The Shockwave Therapy Device report comprises in-depth study of the potential segments including product type, application, and end user and their contribution to the overall market size.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.qyresearch.com/sample-form/form/1969397/global-shockwave-therapy-device-market

In addition, market revenues based on region and country are provided in the Shockwave Therapy Device report. The authors of the report have also shed light on the common business tactics adopted by players. The leading players of the global Shockwave Therapy Device market and their complete profiles are included in the report. Besides that, investment opportunities, recommendations, and trends that are trending at present in the global Shockwave Therapy Device market are mapped by the report. With the help of this report, the key players of the global Shockwave Therapy Device market will be able to make sound decisions and plan their strategies accordingly to stay ahead of the curve.

Competitive landscape is a critical aspect every key player needs to be familiar with. The report throws light on the competitive scenario of the global Shockwave Therapy Device market to know the competition at both the domestic and global levels. Market experts have also offered the outline of every leading player of the global Shockwave Therapy Device market, considering the key aspects such as areas of operation, production, and product portfolio. Additionally, companies in the report are studied based on the key factors such as company size, market share, market growth, revenue, production volume, and profits.

Key Players Mentioned in the Global Shockwave Therapy Device Market Research Report: Boston Scientific Corporation, C.R. Bard Inc., Dornier MedTech GmbH, Lumenis Ltd., Medtrue Enterprise Co. Ltd., Olympus Corporation, Cook Group Inc., Edaptms TMS, Siemens AG, Karl Storz

Global Shockwave Therapy Device Market Segmentation by Product: Mobile Shock Wave Therapy Devices, Fixed Shock Wave Therapy Devices

Global Shockwave Therapy Device Market Segmentation by Application: Hospitals, Physiotherapy Centers, Clinics, Radiology Labs, Others

The Shockwave Therapy Device Market report has been segregated based on distinct categories, such as product type, application, end user, and region. Each and every segment is evaluated on the basis of CAGR, share, and growth potential. In the regional analysis, the report highlights the prospective region, which is estimated to generate opportunities in the global Shockwave Therapy Device market in the forthcoming years. This segmental analysis will surely turn out to be a useful tool for the readers, stakeholders, and market participants to get a complete picture of the global Shockwave Therapy Device market and its potential to grow in the years to come.

Key questions answered in the report:

Request for customization in Report: https://www.qyresearch.com/customize-request/form/1969397/global-shockwave-therapy-device-market

Table of Contents:

1 Study Coverage1.1 Shockwave Therapy Device Product Introduction1.2 Key Market Segments in This Study1.3 Key Manufacturers Covered: Ranking of Global Top Shockwave Therapy Device Manufacturers by Revenue in 20191.4 Market by Type1.4.1 Global Shockwave Therapy Device Market Size Growth Rate by Type1.4.2 Mobile Shock Wave Therapy Devices1.4.3 Fixed Shock Wave Therapy Devices1.5 Market by Application1.5.1 Global Shockwave Therapy Device Market Size Growth Rate by Application1.5.2 Hospitals1.5.3 Physiotherapy Centers1.5.4 Clinics1.5.5 Radiology Labs1.5.6 Others1.6 Study Objectives1.7 Years Considered

2 Executive Summary2.1 Global Shockwave Therapy Device Market Size, Estimates and Forecasts2.1.1 Global Shockwave Therapy Device Revenue Estimates and Forecasts 2015-20262.1.2 Global Shockwave Therapy Device Production Capacity Estimates and Forecasts 2015-20262.1.3 Global Shockwave Therapy Device Production Estimates and Forecasts 2015-20262.2 Global Shockwave Therapy Device, Market Size by Producing Regions: 2015 VS 2020 VS 20262.3 Analysis of Competitive Landscape2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)2.3.2 Global Shockwave Therapy Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)2.3.3 Global Shockwave Therapy Device Manufacturers Geographical Distribution2.4 Key Trends for Shockwave Therapy Device Markets & Products2.5 Primary Interviews with Key Shockwave Therapy Device Players (Opinion Leaders)

3 Market Size by Manufacturers3.1 Global Top Shockwave Therapy Device Manufacturers by Production Capacity3.1.1 Global Top Shockwave Therapy Device Manufacturers by Production Capacity (2015-2020)3.1.2 Global Top Shockwave Therapy Device Manufacturers by Production (2015-2020)3.1.3 Global Top Shockwave Therapy Device Manufacturers Market Share by Production3.2 Global Top Shockwave Therapy Device Manufacturers by Revenue3.2.1 Global Top Shockwave Therapy Device Manufacturers by Revenue (2015-2020)3.2.2 Global Top Shockwave Therapy Device Manufacturers Market Share by Revenue (2015-2020)3.2.3 Global Top 10 and Top 5 Companies by Shockwave Therapy Device Revenue in 20193.3 Global Shockwave Therapy Device Price by Manufacturers3.4 Mergers & Acquisitions, Expansion Plans

4 Shockwave Therapy Device Production by Regions4.1 Global Shockwave Therapy Device Historic Market Facts & Figures by Regions4.1.1 Global Top Shockwave Therapy Device Regions by Production (2015-2020)4.1.2 Global Top Shockwave Therapy Device Regions by Revenue (2015-2020)4.2 North America4.2.1 North America Shockwave Therapy Device Production (2015-2020)4.2.2 North America Shockwave Therapy Device Revenue (2015-2020)4.2.3 Key Players in North America4.2.4 North America Shockwave Therapy Device Import & Export (2015-2020)4.3 Europe4.3.1 Europe Shockwave Therapy Device Production (2015-2020)4.3.2 Europe Shockwave Therapy Device Revenue (2015-2020)4.3.3 Key Players in Europe4.3.4 Europe Shockwave Therapy Device Import & Export (2015-2020)4.4 China4.4.1 China Shockwave Therapy Device Production (2015-2020)4.4.2 China Shockwave Therapy Device Revenue (2015-2020)4.4.3 Key Players in China4.4.4 China Shockwave Therapy Device Import & Export (2015-2020)4.5 Japan4.5.1 Japan Shockwave Therapy Device Production (2015-2020)4.5.2 Japan Shockwave Therapy Device Revenue (2015-2020)4.5.3 Key Players in Japan4.5.4 Japan Shockwave Therapy Device Import & Export (2015-2020)

5 Shockwave Therapy Device Consumption by Region5.1 Global Top Shockwave Therapy Device Regions by Consumption5.1.1 Global Top Shockwave Therapy Device Regions by Consumption (2015-2020)5.1.2 Global Top Shockwave Therapy Device Regions Market Share by Consumption (2015-2020)5.2 North America5.2.1 North America Shockwave Therapy Device Consumption by Application5.2.2 North America Shockwave Therapy Device Consumption by Countries5.2.3 U.S.5.2.4 Canada5.3 Europe5.3.1 Europe Shockwave Therapy Device Consumption by Application5.3.2 Europe Shockwave Therapy Device Consumption by Countries5.3.3 Germany5.3.4 France5.3.5 U.K.5.3.6 Italy5.3.7 Russia5.4 Asia Pacific5.4.1 Asia Pacific Shockwave Therapy Device Consumption by Application5.4.2 Asia Pacific Shockwave Therapy Device Consumption by Regions5.4.3 China5.4.4 Japan5.4.5 South Korea5.4.6 India5.4.7 Australia5.4.8 Taiwan5.4.9 Indonesia5.4.10 Thailand5.4.11 Malaysia5.4.12 Philippines5.4.13 Vietnam5.5 Central & South America5.5.1 Central & South America Shockwave Therapy Device Consumption by Application5.5.2 Central & South America Shockwave Therapy Device Consumption by Country5.5.3 Mexico5.5.3 Brazil5.5.3 Argentina5.6 Middle East and Africa5.6.1 Middle East and Africa Shockwave Therapy Device Consumption by Application5.6.2 Middle East and Africa Shockwave Therapy Device Consumption by Countries5.6.3 Turkey5.6.4 Saudi Arabia5.6.5 U.A.E

6 Market Size by Type (2015-2026)6.1 Global Shockwave Therapy Device Market Size by Type (2015-2020)6.1.1 Global Shockwave Therapy Device Production by Type (2015-2020)6.1.2 Global Shockwave Therapy Device Revenue by Type (2015-2020)6.1.3 Shockwave Therapy Device Price by Type (2015-2020)6.2 Global Shockwave Therapy Device Market Forecast by Type (2021-2026)6.2.1 Global Shockwave Therapy Device Production Forecast by Type (2021-2026)6.2.2 Global Shockwave Therapy Device Revenue Forecast by Type (2021-2026)6.2.3 Global Shockwave Therapy Device Price Forecast by Type (2021-2026)6.3 Global Shockwave Therapy Device Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)7.2.1 Global Shockwave Therapy Device Consumption Historic Breakdown by Application (2015-2020)7.2.2 Global Shockwave Therapy Device Consumption Forecast by Application (2021-2026)

8 Corporate Profiles8.1 Boston Scientific Corporation8.1.1 Boston Scientific Corporation Corporation Information8.1.2 Boston Scientific Corporation Overview8.1.3 Boston Scientific Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)8.1.4 Boston Scientific Corporation Product Description8.1.5 Boston Scientific Corporation Related Developments8.2 C.R. Bard Inc.8.2.1 C.R. Bard Inc. Corporation Information8.2.2 C.R. Bard Inc. Overview8.2.3 C.R. Bard Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)8.2.4 C.R. Bard Inc. Product Description8.2.5 C.R. Bard Inc. Related Developments8.3 Dornier MedTech GmbH8.3.1 Dornier MedTech GmbH Corporation Information8.3.2 Dornier MedTech GmbH Overview8.3.3 Dornier MedTech GmbH Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)8.3.4 Dornier MedTech GmbH Product Description8.3.5 Dornier MedTech GmbH Related Developments8.4 Lumenis Ltd.8.4.1 Lumenis Ltd. Corporation Information8.4.2 Lumenis Ltd. Overview8.4.3 Lumenis Ltd. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)8.4.4 Lumenis Ltd. Product Description8.4.5 Lumenis Ltd. Related Developments8.5 Medtrue Enterprise Co. Ltd.8.5.1 Medtrue Enterprise Co. Ltd. Corporation Information8.5.2 Medtrue Enterprise Co. Ltd. Overview8.5.3 Medtrue Enterprise Co. Ltd. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)8.5.4 Medtrue Enterprise Co. Ltd. Product Description8.5.5 Medtrue Enterprise Co. Ltd. Related Developments8.6 Olympus Corporation8.6.1 Olympus Corporation Corporation Information8.6.2 Olympus Corporation Overview8.6.3 Olympus Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)8.6.4 Olympus Corporation Product Description8.6.5 Olympus Corporation Related Developments8.7 Cook Group Inc.8.7.1 Cook Group Inc. Corporation Information8.7.2 Cook Group Inc. Overview8.7.3 Cook Group Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)8.7.4 Cook Group Inc. Product Description8.7.5 Cook Group Inc. Related Developments8.8 Edaptms TMS8.8.1 Edaptms TMS Corporation Information8.8.2 Edaptms TMS Overview8.8.3 Edaptms TMS Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)8.8.4 Edaptms TMS Product Description8.8.5 Edaptms TMS Related Developments8.9 Siemens AG8.9.1 Siemens AG Corporation Information8.9.2 Siemens AG Overview8.9.3 Siemens AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)8.9.4 Siemens AG Product Description8.9.5 Siemens AG Related Developments8.10 Karl Storz8.10.1 Karl Storz Corporation Information8.10.2 Karl Storz Overview8.10.3 Karl Storz Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)8.10.4 Karl Storz Product Description8.10.5 Karl Storz Related Developments

9 Shockwave Therapy Device Production Forecast by Regions9.1 Global Top Shockwave Therapy Device Regions Forecast by Revenue (2021-2026)9.2 Global Top Shockwave Therapy Device Regions Forecast by Production (2021-2026)9.3 Key Shockwave Therapy Device Production Regions Forecast9.3.1 North America9.3.2 Europe9.3.3 China9.3.4 Japan

10 Shockwave Therapy Device Consumption Forecast by Region10.1 Global Shockwave Therapy Device Consumption Forecast by Region (2021-2026)10.2 North America Shockwave Therapy Device Consumption Forecast by Region (2021-2026)10.3 Europe Shockwave Therapy Device Consumption Forecast by Region (2021-2026)10.4 Asia Pacific Shockwave Therapy Device Consumption Forecast by Region (2021-2026)10.5 Latin America Shockwave Therapy Device Consumption Forecast by Region (2021-2026)10.6 Middle East and Africa Shockwave Therapy Device Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis11.1 Value Chain Analysis11.2 Sales Channels Analysis11.2.1 Shockwave Therapy Device Sales Channels11.2.2 Shockwave Therapy Device Distributors11.3 Shockwave Therapy Device Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis12.1 Shockwave Therapy Device Industry12.2 Market Trends12.3 Market Opportunities and Drivers12.4 Market Challenges12.5 Shockwave Therapy Device Market Risks/Restraints12.6 Porters Five Forces Analysis13 Key Finding in The Global Shockwave Therapy Device Study14 Appendix14.1 Research Methodology14.1.1 Methodology/Research Approach14.1.2 Data Source14.2 Author Details14.3 Disclaimer

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), experts resources (included energy automotive chemical medical ICT consumer goods etc.

More here:

Shockwave Therapy Device Market Overview, Industry Top Manufactures, Market Size, Industry Growth Analysis And Forecasts 2026 |CR Bard Inc., Dornier...